In Brief: Perkin-Elmer/Roche/Amersham:
This article was originally published in The Gray Sheet
Executive Summary
Perkin-Elmer/Roche/Amersham: Companies enter royalty-bearing cross-licensing agreement giving Amersham "non-exclusive licenses and sublicenses" to automated fluorescent DNA sequencing patents owned by Perkin-Elmer, DuPont and the California Institute of Technology and non-exclusive licenses under "certain Roche patents covering thermostable polymerases for use in sequencing." Perkin-Elmer's PE Applied Biosystems division and Roche Molecular Systems receive non-exclusive licenses and sublicenses to patents owned by Amersham and Harvard University "which enable the companies to manufacture, use, and sell a wider range of kits and DNA polymerases for DNA sequencing and fragment analysis"...